David P Bonita's Net Worth

$1.05 Thousand

Estimate Recalculated Jul 22, 2025 10:34PM EST

Who is David P Bonita

David P Bonita does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prelude Therapeutics Inc, SI-BONE, Inc., Repare Therapeutics Inc., ViewRay, Inc., Tricida, Inc., Ikena Oncology, Inc., Loxo Oncology, Inc., Acutus Medical, Inc., IMARA Inc., Third Harmonic Bio, Inc., and AMBIT BIOSCIENCES CORP.

SEC CIK

David P Bonita's CIK is 0001572451

Past Insider Trading and Trends

2022 was David P Bonita's most active year for acquiring shares with 8 total transactions. David P Bonita's most active month to acquire stocks was the month of May. 2013 was David P Bonita's most active year for disposing of shares, totalling 1 transactions. David P Bonita's most active month to dispose stocks was the month of February. 2021 saw David P Bonita paying a total of $0.00 for 131,548 shares, this is the most they've acquired in one year. In 2023 David P Bonita cashed out on 13,667 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Prelude Therapeutics Inc

Investor
Updated Jun 18, 2024
Form 4
23.50K
Jun 18, 2024
23.50K
Grant
Jun 14
Form 4
23.50K
Jun 21, 2023
23.50K
Grant
Jun 16
Form 4
9.40%
869.57K
$5.75
$5.00M
May 24, 2023
10.65M
Purchase
May 22
Form 4
34.30K
Jun 22, 2022
34.30K
Grant
Jun 17
Form 4
23.34K
Jun 22, 2021
23.34K
Grant
Jun 18
Form 4
0.75%
41.70K
$60.00
$2.50M
Jan 12, 2021
5.60M
Purchase
Jan 11
Form 4
33.74%
6.00M
$19.00
$10.00M
Sep 30, 2020
23.78M
Purchase
Mar 27 - Sep 29
Form 3
Sep 24, 2020
206.91K
Showing 8 results

SI-BONE, Inc.

Investor
Updated Oct 19, 2018
Form 4
31.08%
233.64K
$15.00
Oct 19, 2018
985.37K
Purchase
Oct 19
Form 3
Oct 16, 2018
Showing 2 results

Repare Therapeutics Inc.

Investor
Updated Jun 20, 2024
Form 4
27.20K
Jun 20, 2024
27.20K
Grant
Jun 17
Form 4
27.20K
Jun 12, 2023
27.20K
Grant
Jun 08
Form 4
49.00K
May 16, 2022
49.00K
Grant
May 13
Form 4
-0.12%
-8.08K
$33.97
-$274.79K
Sep 08, 2021
6.55M
Sale
ScheduledSep 03 - Sep 07
Form 4
-0.38%
-37.86K
$34.05
-$1.29M
Sep 02, 2021
9.89M
Sale
ScheduledAug 31 - Sep 02
Form 4
-0.18%
-18.07K
$34.13
-$615.75K
Aug 30, 2021
9.98M
Sale
ScheduledAug 26 - Aug 30
Form 4
-0.18%
-18.21K
$34.16
-$622.43K
Aug 25, 2021
10.03M
Sale
ScheduledAug 23 - Aug 25
Form 4
-0.30%
-20.33K
$34.06
-$693.21K
Aug 25, 2021
6.71M
Sale
ScheduledAug 17 - Aug 18
Form 4
-0.30%
-20.33K
$34.06
-$693.21K
Aug 19, 2021
6.71M
Sale
ScheduledAug 17 - Aug 18
Form 4
21.00K
May 14, 2021
21.00K
Grant
May 13
Form 4
29.76%
774.20K
$20.00
$1.98M
Jun 25, 2020
3.38M
Purchase
Jun 23
Form 3
Jun 18, 2020
Showing 12 results

ViewRay, Inc.

Investor
Updated Apr 25, 2018
Form 4
268.75%
52.49K
Apr 25, 2018
9.53M
Grant
Nov 15
Form 4
4.19%
396.69K
$1.57
$1.00M
Jan 20, 2017
9.87M
Purchase
Jan 18
Form 4
19.53K
Sep 15, 2016
9.15M
Grant
Sep 13
Form 4
18.52%
1.48M
$1.54
$3.40M
Aug 24, 2016
9.47M
Purchase
Aug 22
Form 3
Mar 30, 2016
7.99M
Showing 5 results

Tricida, Inc.

Investor
Updated Nov 25, 2022
Form 4
-100.00%
-10.28M
$0.21
-$2.21M
Nov 25, 2022
Sale
Nov 22 - Nov 25
Form 4
27.21K
Jun 16, 2022
27.21K
Grant
Jun 15
Form 4
13.87%
1.33M
$6.00
$4.00M
Nov 17, 2021
10.98M
Grant
Nov 15
Form 4
658.60%
73.64K
Jun 11, 2021
9.70M
Grant
Jun 10
Form 4
519.63%
28.64K
Jun 15, 2020
9.65M
Grant
Jun 11
Form 4
-13.50%
-1.50M
$40.00
-$60.00M
Dec 12, 2019
9.62M
Sale
Dec 11
Form 4
246.34%
8.95K
Jun 04, 2019
11.13M
Grant
May 31
Form 4
2.07%
225.00K
$36.00
$8.10M
Apr 05, 2019
11.11M
Purchase
Apr 03
Form 4
-73.95%
-30.97M
$19.00
Jul 02, 2018
10.91M
Buy-Options
Jul 02
Form 3
Jun 27, 2018
Showing 10 results

Ikena Oncology, Inc.

Investor
Updated Jun 10, 2024
Form 4
17.52K
Jun 10, 2024
17.52K
Grant
Jun 07
Form 4/A
9.33%
506.31K
Sep 21, 2023
8.28M
Grant
Aug 04
Form 4
24.13%
506.31K
Sep 14, 2023
8.28M
Grant
Aug 04
Form 4
17.52K
Jun 13, 2023
17.52K
Grant
Jun 09
Form 4
-12.74%
-252.22K
$4.47
-$1.13M
Jun 24, 2022
7.78M
p
Jun 22 - Jun 24
Form 4
13.42K
Jun 13, 2022
13.42K
Grant
Jun 09
Form 4
13.42K
Dec 23, 2021
13.42K
Grant
Dec 21
Form 4/A
125.29%
10.79M
$8.70
$21.27M
Apr 14, 2021
19.40M
Purchase
Dec 21 - Mar 30
Form 4
120.10%
10.79M
$8.70
$21.27M
Apr 01, 2021
19.78M
Purchase
Dec 21 - Mar 30
Form 3
Mar 25, 2021
Showing 10 results

Loxo Oncology, Inc.

Investor
Updated Dec 12, 2017
Form 4
-20.99%
-250.00K
$82.50
-$20.62M
Dec 12, 2017
941.00K
Sale
Dec 08
Form 4
-18.31%
-267.00K
$75.00
-$20.02M
Nov 27, 2017
1.19M
Sale
Nov 22
Form 4
-15.62%
-270.00K
$74.26
-$20.05M
Nov 20, 2017
1.46M
Sale
Nov 16
Form 4
11.00K
Jun 23, 2017
11.00K
Grant
Jun 22
Form 4
-20.58%
-447.86K
$26.96
-$12.07M
Aug 12, 2016
1.73M
Sale
Aug 10
Form 4
7.81K
Jun 13, 2016
7.81K
Grant
Jun 10
Form 4
7.81K
Jul 30, 2015
7.81K
Grant
Jul 28
Form 4
14.49%
275.38K
$13.00
Aug 06, 2014
2.18M
Purchase
Aug 06
Form 4
15.63K
Aug 01, 2014
15.63K
Grant
Jul 31
Form 3
Jul 31, 2014
Showing 10 results

Acutus Medical, Inc.

Investor
Updated Jun 15, 2023
Form 4
225.41%
28.00K
Jun 15, 2023
40.42K
Grant
Jun 15
Form 4
696.17%
28.00K
Jun 21, 2022
6.58M
Grant
Jun 16
Form 4
19.56%
1.07M
$14.00
$15.00M
Jul 21, 2021
6.55M
Purchase
Jul 19
Form 4
397.03%
8.82K
Jun 22, 2021
5.49M
Grant
Jun 17
Form 4
7.58%
415.00K
$18.00
$7.47M
Aug 12, 2020
5.90M
Purchase
Aug 10
Form 4
14.68K
Aug 07, 2020
14.68K
Grant
Aug 05
Form 3
Aug 05, 2020
Showing 7 results

IMARA Inc.

Investor
Updated Jun 03, 2022
Form 4
8.50K
Jun 03, 2022
4.21M
Grant
Jun 02
Form 4/A
65.81%
1.67M
$6.00
$10.00M
Jul 23, 2021
4.20M
Purchase
Jul 16
Form 4
1.67M
$6.00
$10.00M
Jul 16, 2021
4.20M
Purchase
Jul 16
Form 4
7.73K
Jun 30, 2021
2.54M
Grant
Jun 29
Form 4
-74.64%
-7.50M
$16.00
Mar 16, 2020
2.55M
Buy-Options
Mar 12 - Mar 16
Form 3
Mar 11, 2020
Showing 6 results

Third Harmonic Bio, Inc.

Investor
Updated Jun 10, 2024
Form 4
20.00K
Jun 10, 2024
20.00K
Grant
Jun 06
Form 4
16.25K
Jun 08, 2023
16.25K
Grant
Jun 06
Form 4
Mar 08, 2023
13.67K
Acq/Dis
Mar 06
Form 4
13.67K
Oct 27, 2022
13.67K
Grant
Oct 26
Form 4
-53.31%
-6.60M
$17.00
Sep 21, 2022
5.78M
Buy-Options
Sep 19
Form 3
Sep 14, 2022
Showing 6 results

AMBIT BIOSCIENCES CORP

Investor
Updated May 16, 2014
Form 4
8.00K
May 16, 2014
8.00K
Grant
May 15
Form 4
2.32%
33.80K
$6.91
$233.51K
May 24, 2013
1.49M
Purchase
May 22 - May 23
Form 4
-90.98%
-14.77M
$7.97
May 22, 2013
1.46M
Buy-Options
May 20 - May 21
Form 3
May 15, 2013
309.00
Showing 4 results